Deutsche Bank reiterated Victrex PLC (LON:VCT) to Hold in a report released today.
- Updated: September 27, 2016
Yesterday Victrex PLC (LON:VCT) traded 0.00% even at 0.00GBX. The company’s 50-day moving average is 1,531.46GBX and its 200-day moving average is 1,514.47GBX. The last closing price is down 0.43% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 340,797 shares of the stock were exchanged, up from an average trading volume of 260,937
Deutsche Bank has reiterated Victrex PLC (LON:VCT) to Hold in a report released on 9/28/2016. They are also indicating a possible upside of 0%.
Previously on 9/16/2016, Exane BNP Paribas reported on Victrex PLC (LON:VCT) raised the target price from 0.00GBX to 1,450.00GBX. At the time, this indicated a possible downside of -0.03%.
See Chart Below
Victrex PLC has a 52 week low of 1,275.58GBX and a 52 week high of 1,961.00GBX with a P/E ratio of 16.23 VCT’s total market value is presently 0 GBX.
A total of 15 equity analysts have released a ratings update on VCT. Four equity analysts rating the company a strong buy, two brokerages rating the company a buy, nine brokerages rating the company a hold, one brokerage rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 1,716.00GBX.
More About Victrex PLC (LON:VCT)
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of high performance polymers. The Company's operating segments are Victrex Polymer Solutions and Invibio Biomaterial Solutions. The Victrex Polymer Solutions segment focuses on its automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. It offers its services to over 15,000 aircrafts in approximately 40 countries across the world. The Company intends to focus on polyaryletherketones (PAEK) in automotive, aerospace, electronics and energy, downstream integration opportunities and extending into other markets. It also focuses on spine, trauma, dental and orthopedics, delivering solutions based on polyetheretherketone (PEEK) and other enabling polymers. The Company's subsidiaries include Victrex Manufacturing Limited, Invibio Limited and Victrex Trading Limited.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.